Floatz logo

BMS-986345

Extranodal NK-/T-cell Lymphoma, Nasal Type

National Cancer Institute (NCI)Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Extranodal NK-/T-cell Lymphoma, Nasal Type cohort.

Asset / SponsorPhaseRating
Inno-206
National Cancer Institute (NCI)
Phase 1CC
Duvelisib
National Cancer Institute (NCI)
Phase 1CC
Azacitidine
National Cancer Institute (NCI)
Phase 1CC

Same molecule, other indications

BMS-986345 is also rated in:

Chronic Lymphocytic LeukemiaDormant
B
Indicative ·
58 / 100
View asset →
Follicular LymphomaDormant
B
Indicative ·
56 / 100
View asset →
Indolent Non-Hodgkin LymphomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →